Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Eukaryotic Gene Expression
Импакт фактор: 1.841 5-летний Импакт фактор: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Печать: 1045-4403
ISSN Онлайн: 2162-6502

Выпуски:
Том 30, 2020 Том 29, 2019 Том 28, 2018 Том 27, 2017 Том 26, 2016 Том 25, 2015 Том 24, 2014 Том 23, 2013 Том 22, 2012 Том 21, 2011 Том 20, 2010 Том 19, 2009 Том 18, 2008 Том 17, 2007 Том 16, 2006 Том 15, 2005 Том 14, 2004 Том 13, 2003 Том 12, 2002 Том 11, 2001 Том 10, 2000 Том 9, 1999 Том 8, 1998 Том 7, 1997 Том 6, 1996 Том 5, 1995 Том 4, 1994

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2019029088
pages 377-385

Review of Anti-Bacterial Activities of Curcumin against Pseudomonas aeruginosa

Zohreh Neyestani
Department of Microbiology, Faculty of Sciences, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran
Seyed Ali Ebrahimi
Student Research Committee, Islamic Azad University, Mashhad branch, Mashhad, Iran
Anahita Ghazaghi
Student Research Committee, Islamic Azad University, Mashhad branch, Mashhad, Iran
Amin Jalili
Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Amirhossein Sahebkar
Halal Research Center of IRI, FDA, Tehran, Iran; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Hamid Reza Rahimi
Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Краткое описание

The prevention and pharmacotherapy of infectious diseases are of great importance. Among others, infections caused by Pseudomonas aeruginosa have a high mortality rate. This bacterium is the third most common cause of nosocomial infections, and characteristics such as multiple virulence factors, ability to survive, environmental spread, and resistance to antibiotics have made it a potential pathogen, especially for people with compromised immune systems. Considering bacterial resistance to current medications, high cost, and side effects, the need to provide new and effective therapies is highlighted. Curcumin is a dietary polyphenolic compound that has a wide range of therapeutic properties, including antibacterial effects. It has been the subject of increasing research exploring its potential utility in infectious diseases. In this review, the antibacterial effects of curcumin against Pseudomonas aeruginosa are discussed.

ЛИТЕРАТУРА

  1. Jagetia GC, Aggarwal BB. "Spicing up" of the immune system by curcumin. J Clin Immunol. 2007;27(1):19-35.

  2. Rahimi HR, Kazemi Oskuee R. Curcumin from traditional Iranian medicine to molecular medicine. Razavi Int J Med. 2014;2(2):e19982.

  3. Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, Sahebkar A. Phytosomal curcumin: a review of pharma-cokinetic, experimental and clinical studies. Biomed Pharmacother. 2017;85:102-12.

  4. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Alt Comp Med. 2003;9(1):161-8.

  5. Khurana A, Ho C-T. High performance liquid chro-matographic analysis of curcuminoids and their photo-oxidative decomposition compounds in Curcuma longa L. J Liquid Chromatography. 1988;11(11):2295-304.

  6. Zorofchian Moghadamtousi S, Abdul Kadir H, Hassan-darvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. BioMed Res Int. 2014;186864.

  7. Momtazi AA, Shahabipour F, Khatibi S, Johnston TP, Pirro M, Sahebkar A. Curcumin as a microRNA regulator in cancer: a review. Rev Physiol Biochem Pharmacol. 2016;171:1-38.

  8. Karimian MS, Pirro M, Majeed M, Sahebkar A. Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine Growth Factor Rev. 2017;33:55-63.

  9. Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mendia LE, Sahebkar A. Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: a randomized controlled trial. J Cardiovasc Pharmacol. 2016;68(3):223-9.

  10. Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann New YorkAcad Sci. 2005;1056(1):206-17.

  11. Vogel A, Pelletier J. Examen chimique de la racine de curcuma. J Pharm. 1815;1:289-300.

  12. Vogel A. Memoire sur la curcumine. J de Pharm et Chim. 1842;2:20-7.

  13. Lampe V, Milobedzka J. Studien uber curcumin. Berichte der Deutschen Chemischen Gesellschaft. 1913;46(2):2235-40.

  14. Srinivasan K. A chromatographic study of the curcuminoids in Curcuma longa L. J Pharm Pharmacol. 1953;5(1):448-57.

  15. Tennesen HH, Karlsen J. Studies on curcumin and curcuminoids. Zeitschrift fur Lebensmitteluntersuchung und-Forschung A. 1985;180(5):402-4.

  16. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78(18):2081-7.

  17. Hatcher H, Planalp R, Cho J, Torti F, Torti S. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65(11):1631-52.

  18. Rahimi HR, Jaafari MR, Mohammadpour AH, Abnous K, Ghayour Mobarhan M, Ramezanzadeh E, Mousavi F, Kazemi Oskuee R. Curcumin: reintroduced therapeutic agent from traditional medicine for alcoholic liver disease. Asia Pacific J Med Toxicol. 2015;4(1):25-30.

  19. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Thomas P, Dannenberg AJ. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kB-dependent genes. Am J Physiolo-Gastrointestinal Liver Physiol. 2003;284(2):G321-7.

  20. Rahimi HR, Mohammadpour AH, Dastani M, Jaafari MR, Abnous K, Mobarhan MG, Oskuee RK. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial. Avicenna J Phytomed. 2016;6(5):567.

  21. Mohammadi A, Sahebkar A, Iranshahi M, Amini M, Khojasteh R, Ghayour-Mobarhan M, Ferns GA. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytother Res. 2013;27(3):374-9.

  22. Hosseini S, Chamani J, Rahimi H, Azmoodeh N, Ghasemi F, Abadi PH. An in vitro study on curcumin delivery by nano-micelles for esophageal squamous cell carcinoma (KYSE-30). Rep Biochem Mol Biol. 2018;6(2):137.

  23. Singh S. From exotic spice to modern drug? Cell. 2007;130(5):765-8.

  24. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, Sprenger M. Antimicrobial resistance is a major threat to public health. BMJ (Clin Res Ed). 1998;317(7159):609-10.

  25. Rudrappa T, Bais HP. Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models. J Agricultural Food Chem. 2008;56(6): 1955-62.

  26. Niamsa N, Sittiwet C. Antimicrobial activity of Curcuma longa aqueous extract. J Pharmacol Toxicol. 2009;4(4):173-7.

  27. Neelofar K, Shreaz S, Rimple B, Muralidhar S, Nikhat M, Khan LA. Curcumin as a promising anticandidal of clinical interest. Can J Microbiol. 2011;57(3):204-10.

  28. Lawhavinit O-a, Kongkathip N, Kongkathip B. Antimicrobial activity of curcuminoids from Curcuma longa L. on pathogenic bacteria of shrimp and chicken. Kasetsart J-Natural Sci. 2010;44(3):364-71.

  29. Hosny I, El Kholy W, Murad H, El Dairouty R. Antimicrobial activity of curcumin upon pathogenic microorganisms during manufacture and storage of a novel style cheese "Karishcum." J Am Sci. 2011;7(5):611-8.

  30. De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, Nair GB, Mukhopadhyay AK. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother. 2009;53(4):1592-7.

  31. Tajbakhsh S, Mohammadi K, Deilami I, Zandi K, Fouladvand M, Ramedani E, Asayesh G. Antibacterial activity of indium curcumin and indium diacetylcurcumin. African J Biotechnol. 2008;7(21).

  32. Odds FC. Synergy, antagonism, and what the chequer-board puts between them. J Antimicrob Chemother. 2003;52(1):1.

  33. Tyagi P, Singh M, Kumari H, Kumari A, Mukhopadhyay K. Bactericidal activity of curcumin I is associated with damaging of bacterial membrane. PLoS One. 2015;10(3):e0121313.

  34. Mirnejad R, Jahromi M, Ali M, Al-Musawi S, Pirestani M, Fasihi Ramandi M, Ahmadi K, Rajayi H, Mohammad Hassan Z, Kamali M. Curcumin-loaded chitosan tripoly-phosphate nanoparticles as a safe, natural and effective antibiotic inhibits the infection of Staphylococcus aureus and Pseudomonas aeruginosa in vivo. Iranian J Biotechnol. 2014;12(3):1-8.

  35. Mun S-H, Joung D-K, Kim Y-S, Kang O-H, Kim S-B, Seo Y-S, Kim Y-C, Lee D-S, Shin D-W, Kweon K-T. Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine. 2013;20(8-9):714-8.

  36. Hatamie S, Nouri M, Karandikar S, Kulkarni A, Dhole S, Phase D, Kale S. Complexes of cobalt nanoparticles and polyfunctional curcumin as antimicrobial agents. Mater Sci Eng: C. 2012;32(2):92-7.

  37. Varaprasad K, Mohan YM, Vimala K, Mohana Raju K. Synthesis and characterization of hydrogel-silver nanoparticle-curcumin composites for wound dressing and antibacterial application. J Appl Polymer Sci. 2011;121(2):784-96.

  38. Hancock REW, Decad GM, Nikaido H. Identification of the protein producing transmembrane diffusion pores in the outer membrane of Pseudomonas aeruginosa PA01. Biochim Biophys Acta-Biomembranes. 1979;554(2):323-31.

  39. Hancock RE, Nikaido H. Outer membranes of Gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier. J Bacteriol. 1978;136(1): 381-90.

  40. Sykes RB, Morris A. Resistance of Pseudomonas Aeruginosa to Antimicrobial Drugs. In: Ellis GP, West GB, editors. Progress in medicinal chemistry. vol. 12. New York: Elsevier; 1975. p. 333-93.

  41. Yoshimura F, Nikaido H. Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes. J Bacteriol. 1982;152(2):636-42.

  42. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 2002;34(5):634-40.

  43. Aeschlimann JR. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other Gram-negative bacteria. Pharmacother: J Human Pharmacol Drug Ther. 2012;23(7):916-24.

  44. Miller MB, Bassler BL. Quorum sensing in bacteria. Ann Rev Microbiol. 2001;55:165-99.

  45. Vert M, Doi Y, Hellwich K-H, Hess M, Hodge P, Kubisa P, Rinaudo M, Schue F. Terminology for biorelated polymers and applications (IUPAC Recommendations 2012). Pure Appl Chem. 2012. 2012;84:377-410.

  46. Aghamollaei H, Azizi Baijini K, Moosazadeh Mogaddam M. Rapid detection of Pseudomonas aeruginosa by PCR method using specific primers of quorum sensing lasI gene. Armaghane Danesh. 2013;18(9):723-35.

  47. Negi N, Prakash P, Gupta ML, Mohapatra TM. Possible role of curcumin as an efflux pump inhibitor in multi drug resistant clinical isolates of Pseudomonas aeruginosa. J Clin Diagn Res. 2014;8(10):DC04.

  48. Miller MB, Bassler BL. Quorum sensing in bacteria. Ann Rev Microbiol. 2001;55(1):165-99.

  49. Zhu H, Bandara R, Conibear TC, Thuruthyil SJ, Rice SA, Kjelleberg S, Givskov M, Willcox MD. Pseudomonas aeruginosa with lasI quorum-sensing deficiency during corneal infection. Invest Ophthalmol Vis Sci. 2004;45(6):1897-903.

  50. Sharma G, Rao S, Bansal A, Dang S, Gupta S, Gabrani R. Pseudomonas aeruginosa biofilm: potential therapeutic targets. Biologicals. 2014;42(1):1-7.

  51. Senturk S, Ulusoy S, Bosgelmez-Tinaz G, Yagci A. Quorum sensing and virulence of Pseudomonas aeruginosa during urinary tract infections. J Infect Develop Countries. 2012;6(06):501-7.

  52. Kumar R, Chhibber S, Gupta V, Harjai K. Screening and profiling of quorum sensing signal molecules in Pseudomonas aeruginosa isolates from catheterized urinary tract infection patients. Indian J Med Res. 2011; 134(2):208.

  53. Chowdhury N, Bagchi A. Molecular insight into the activity of LasR protein from Pseudomonas aeruginosa in the regulation of virulence gene expression by this organism. Gene. 2016;580(1):80-7.

  54. Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Antimicrobial resistance. JAMA. 2016;316(11): 1193-204.

  55. Betts JW, Wareham DW. In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii. BMC Microbiol. 2014;14(1):172.

  56. Bahari S, Zeighami H, Mirshahabi H, Roudashti S, Haghi F. Inhibition of Pseudomonas aeruginosa quorum sensing by subinhibitory concentrations of curcumin with gentamicin and azithromycin. J Global Antimicrob Resist. 2017;10:21-8.

  57. Packiavathy IASV, Priya S, Pandian SK, Ravi AV. Inhibition of biofilm development of uropathogens by curcumin-an anti-quorum sensing agent from Curcuma longa. Food Chem. 2014;148:453-60.

  58. Cuomo J, Appendino G, Dern AS, Schneider E, McKinnon TP, Brown MJ, Togni S, Dixon BM.Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Natur Prod. 2011; 74(4):664-9.

  59. Sasidharan NK, Sreekala SR, Jacob J, Nambisan B. In vitro synergistic effect of curcumin in combination with third generation cephalosporins against bacteria associated with infectious diarrhea. BioMed Res Int. 2014; 2014:8.

  60. Kali A, Devaraj Bhuvaneshwar P, Charles M, Seetha KS. Antibacterial synergy of curcumin with antibiotics against biofilm producing clinical bacterial isolates. J Basic Clin Pharm. 2016;7(3):93.